Workers at Amazon Warehouse in North Carolina Push for Unionization

US
Published:

An independent group of workers at an Amazon warehouse in Garner, North Carolina, is moving forward with plans to form a union, potentially becoming the second unionized Amazon facility in the United States. The Carolina Amazonians United for Solidarity and Empowerment has filed for an election, which is sanctioned by the National Labor Relations Board (NLRB) and is set to take place from February 10 to February 15, 2025.

The election will involve approximately 4,300 employees at the 700,000 square foot warehouse located in the Raleigh suburbs. Since early 2022, the organizing group has advocated for improvements in pay, scheduling, paid time off, accommodations for injured or disabled workers, and overall workplace respect.

Rev. Ryan Brown, a co-founder of the group, cited inspiration from previous union elections at Amazon, particularly a notable election in Bessemer, Alabama in 2021. Despite some setbacks in the past, Brown emphasized the importance of workers standing up for their rights amidst concerns over workplace conditions.

Brown, who was terminated from his job at Amazon, described the challenges faced by the organizing group in North Carolina—a state with a low union density of 2.7% in 2023. He noted that community organizing, often centered around local churches, played a pivotal role in their efforts.

Amazon has responded to the union efforts, claiming they provide safe workplaces and competitive benefits. Spokesperson Eileen Hards expressed hope that the election process will allow employees to have their voices heard directly. The outcome of the upcoming vote could have significant implications for unionization efforts at Amazon facilities across the country.

Weekly Newsletter

News summary by melangenews

Loading...

More from United States

Tragic Collision of Passenger Plane and Military Helicopter in Washington Claims 67 Lives

A catastrophic midair collision between a passenger plane and a military helicopter in Washington D.C. on Wednesday resulted in the deaths of all 67 individuals on board. The incident involved American Airlines flight 5342, which was a Bombardier CRJ-700 carrying 60 passengers and four crew members, and a military Sikorsky H-60 Black Hawk helicopter occupied by three service members. The collision occurred over the Potomac River at approximately 8:48 PM local time while the plane was making its final approach to Ronald Reagan Airport. Eyewitness reports indicated that the helicopter veered dangerously close to the aircraft before the impact, causing both to explode in midair. Emergency teams recovered 28 bodies from the plane and one from the helicopter, confirming that no survivors emerged from the wreckage. American Airlines expressed its condolences and stated that it is cooperating with investigation efforts, while President Donald Trump commented on the tragedy, stating it "seemed avoidable" given the clear weather conditions and routine approach procedure. A joint investigation by civil and military authorities is underway to determine the accident's cause.
US

FDA Approves Revolutionary Bioengineered Blood Vessel for Trauma Treatments

The U.S. Food and Drug Administration (FDA) has approved a groundbreaking bioengineered blood vessel aimed at addressing the needs of trauma patients. Developed by North Carolina-based Humacyte, this vessel is designed to integrate with a patient’s body over time, providing a solution for individuals who have suffered severe injuries that impede blood circulation, particularly in cases of amputation. According to founder and CEO Laura Niklason, traditional treatments using veins are often inadequate, especially when patients cannot provide usable options from their own bodies. The FDA approval follows extensive testing involving 51 civilian and 16 military patients, revealing that nearly 92% of the engineered vessels remained functional after 30 days, compared to 79% for synthetic alternatives. Additionally, the infection rate for the bioengineered vessels was under 1%, significantly lower than the over 8% rate associated with synthetic grafts, as published in the journal JAMA Surgery. While the approved application is limited to trauma cases, Humacyte is exploring additional uses for its technology, including potential applications in kidney dialysis and peripheral artery disease.
US

Trump Plans to Detain 30,000 Migrants at Guantanamo Bay

Former President Donald Trump has outlined a controversial plan to detain up to 30,000 migrants at the Guantanamo Bay detention facility if he is re-elected in 2024. According to a statement released by Trump's campaign, this measure aims to address illegal immigration and bolster national security. This proposal comes amidst intensifying discussions on immigration policies in the United States, reflecting Trump's previously embraced hardline stance during his presidency. Trump's administration was marked by strict immigration measures, including family separations and the construction of barriers along the U.S.-Mexico border. Critics of the plan have raised concerns about humanitarian implications and the legality of detaining a large number of migrants indefinitely. Legal experts argue that such actions could face significant pushback in courts. The proposal reflects a broader trend among certain political leaders advocating for stringent immigration control as a response to increasing cross-border migration. As the 2024 presidential election approaches, Trump's immigration policy is expected to be a focal point of debate among candidates.
US